tiprankstipranks
New Ray Medicine’s H1 Revenue Plummets, Losses Narrow
Company Announcements

New Ray Medicine’s H1 Revenue Plummets, Losses Narrow

New Ray Medicine International Holding Ltd. (HK:6108) has released an update.

Don't Miss Our Christmas Offers:

New Ray Medicine International Holding Ltd. reported a significant decrease in revenue for the first half of 2024, with a 46.1% drop compared to the same period in 2023, along with a reduction in net loss by 69.4%. The company, which did not declare an interim dividend, also showed a substantial comprehensive expense for the period, reflecting continued financial challenges.

For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App